123 related articles for article (PubMed ID: 14762685)
1. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685
[TBL] [Abstract][Full Text] [Related]
2. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.
Chim CS; Fung TK; Cheung WC; Liang R; Kwong YL
Blood; 2004 Jun; 103(12):4630-5. PubMed ID: 14976049
[TBL] [Abstract][Full Text] [Related]
3. SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway.
Chim CS; Wong KY; Loong F; Srivastava G
Leukemia; 2004 Feb; 18(2):356-8. PubMed ID: 14614518
[No Abstract] [Full Text] [Related]
4. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
Cheng J; Zhang D; Zhou C; Marasco WA
Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
[TBL] [Abstract][Full Text] [Related]
6. Control mechanism of JAK/STAT signal transduction pathway.
Yamada S; Shiono S; Joo A; Yoshimura A
FEBS Lett; 2003 Jan; 534(1-3):190-6. PubMed ID: 12527385
[TBL] [Abstract][Full Text] [Related]
7. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.
Reddy J; Shivapurkar N; Takahashi T; Parikh G; Stastny V; Echebiri C; Crumrine K; Zöchbauer-Müller S; Drach J; Zheng Y; Feng Z; Kroft SH; McKenna RW; Gazdar AF
Oncogene; 2005 Jan; 24(4):732-6. PubMed ID: 15580314
[TBL] [Abstract][Full Text] [Related]
8. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.
O'Shea JJ; Gadina M; Schreiber RD
Cell; 2002 Apr; 109 Suppl():S121-31. PubMed ID: 11983158
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
[TBL] [Abstract][Full Text] [Related]
10. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia.
Chen CY; Tsay W; Tang JL; Shen HL; Lin SW; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
Genes Chromosomes Cancer; 2003 Jul; 37(3):300-5. PubMed ID: 12759928
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Janus kinase 2 by cisplatin in cancer cells.
Song H; Sondak VK; Barber DL; Reid TJ; Lin J
Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia.
Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT
Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956
[TBL] [Abstract][Full Text] [Related]
13. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
Zhang MY; Fung TK; Chen FY; Chim CS
J Cell Mol Med; 2013 Oct; 17(10):1282-90. PubMed ID: 24131863
[TBL] [Abstract][Full Text] [Related]
14. Silencing of negative regulator of JAK/STAT in colorectal cancer.
Endo T; Toyota M; Imai K
J Gastroenterol; 2004; 39(2):200-1. PubMed ID: 15198092
[No Abstract] [Full Text] [Related]
15. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
16. [Cytokine receptors and signal transduction].
Nakajima H; Kitamura T
Nihon Rinsho; 2005 Apr; 63 Suppl 4():178-86. PubMed ID: 15861654
[No Abstract] [Full Text] [Related]
17. Expression of interferon alfa signaling components in human alcoholic liver disease.
Nguyen VA; Gao B
Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
[TBL] [Abstract][Full Text] [Related]
18. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.
Wierenga AT; Schuringa JJ; Eggen BJ; Kruijer W; Vellenga E
Leukemia; 2002 Apr; 16(4):675-82. PubMed ID: 11960349
[TBL] [Abstract][Full Text] [Related]
20. SHP1 protein tyrosine phosphatase negatively modulates erythroid differentiation and suppression of apoptosis in J2E erythroleukemic cells.
Bittorf T; Seiler J; Zhang Z; Jaster R; Brock J
Biol Chem; 1999 Oct; 380(10):1201-9. PubMed ID: 10595583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
